{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:42:43Z","timestamp":1793475763317,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.intimp.2024.113955","type":"journal-article","created":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T18:58:52Z","timestamp":1735757932000},"page":"113955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["RBM47 as a potential therapeutic target for thyroid-associated ophthalmopathy"],"prefix":"10.1016","volume":"147","author":[{"given":"Ru","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Jie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fa-Gang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.intimp.2024.113955_b0005","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2213-8587(21)00268-0","article-title":"Statins for Graves' orbitopathy: a new tool for prevention and treatment?","volume":"9","author":"Bartalena","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"10.1016\/j.intimp.2024.113955_b0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4274\/tjo.80688","article-title":"Thyroid-associated Ophthalmopathy","volume":"47","author":"\u015eahl\u0131","year":"2017","journal-title":"Turkish J. Ophthalmol."},{"key":"10.1016\/j.intimp.2024.113955_b0015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.exer.2015.02.007","article-title":"Current perspectives on the role of orbital fibroblasts in the pathogenesis of Graves' ophthalmopathy","volume":"142","author":"Dik","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.intimp.2024.113955_b0020","unstructured":"X.L. Chen, W.M. He, W. Li, [Effects and Its Mechanism of IGF-1R on the Synthesis of Hyaluronic Acid in Orbital Fibroblasts of Thyroid Associated Ophthalmopathy], Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Med. Sci. Ed. 48(5) (2017) 727\u2013731."},{"issue":"4","key":"10.1016\/j.intimp.2024.113955_b0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.intimp.2024.113955_b0030","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S2213-8587(18)30022-6","article-title":"Graves' orbitopathy: the ongoing search for new treatment strategies","volume":"6","author":"Dalm","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.intimp.2024.113955_b0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.molcel.2020.03.011","article-title":"How RNA-binding proteins interact with RNA: molecules and mechanisms","volume":"78","author":"Corley","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.intimp.2024.113955_b0040","article-title":"RBP-RNA interactions in the control of autoimmunity and autoinflammation","author":"Liu","year":"2023","journal-title":"Cell Res."},{"issue":"7920","key":"10.1016\/j.intimp.2024.113955_b0045","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41586-022-04974-w","article-title":"ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation","volume":"607","author":"de Reuver","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.intimp.2024.113955_b0050","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41590-018-0262-4","article-title":"G3BP1 promotes DNA binding and activation of cGAS","volume":"20","author":"Liu","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.113955_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155417","article-title":"Dioscin decreases M2 polarization via inhibiting a positive feedback loop between RBM47 and NF-\u03baB in glioma","volume":"128","author":"Bai","year":"2024","journal-title":"Phytomed.: Int. J. Phytotherapy Phytopharm."},{"issue":"4","key":"10.1016\/j.intimp.2024.113955_b0060","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1007\/s10528-023-10590-8","article-title":"Post-transcriptional regulator RBM47 stabilizes FBXO2 mRNA to advance osteoarthritis development: WGCNA analysis and experimental validation","volume":"62","author":"Tang","year":"2024","journal-title":"Biochem. Genet."},{"issue":"8","key":"10.1016\/j.intimp.2024.113955_b0065","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202052205","article-title":"RNA-binding protein RBM47 stabilizes IFNAR1 mRNA to potentiate host antiviral activity","volume":"22","author":"Wang","year":"2021","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.intimp.2024.113955_b0070","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41423-018-0041-z","article-title":"Post-transcriptional regulator Rbm47 elevates IL-10 production and promotes the immunosuppression of B cells","volume":"16","author":"Wei","year":"2019","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.intimp.2024.113955_b0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/1874364101812010041","article-title":"Transcriptome analysis of orbital adipose tissue in active thyroid eye disease using next generation RNA sequencing technology","volume":"12","author":"Lee","year":"2018","journal-title":"Open Ophthalmol. J."},{"issue":"8","key":"10.1016\/j.intimp.2024.113955_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087012","article-title":"Prostaglandin F2\u03b1 regulates adipogenesis by modulating extracellular signal-regulated kinase signaling in graves' ophthalmopathy","volume":"24","author":"Zhu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.intimp.2024.113955_b0085","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1039\/C9BM02080B","article-title":"Melittin-encapsulating peptide hydrogels for enhanced delivery of impermeable anticancer peptides","volume":"8","author":"Feng","year":"2020","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2024.113955_b0090","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12885-023-10527-9","article-title":"TAP1, a potential immune-related prognosis biomarker with functional significance in uveal melanoma","volume":"23","author":"Zhu","year":"2023","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.intimp.2024.113955_b0095","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.181.6.4397","article-title":"Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in graves\u2019 disease1","volume":"181","author":"Tsui","year":"2008","journal-title":"J. Immunol."},{"issue":"48","key":"10.1016\/j.intimp.2024.113955_b0100","doi-asserted-by":"crossref","first-page":"46226","DOI":"10.1074\/jbc.M207776200","article-title":"Activation of MEK\/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C\/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes","volume":"277","author":"Prusty","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2024.113955_b0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/iovs.63.10.6","article-title":"Potential therapeutic activity of berberine in thyroid-associated ophthalmopathy: inhibitory effects on tissue remodeling in orbital fibroblasts","volume":"63","author":"Diao","year":"2022","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2024.113955_b0110","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ecl.2021.12.004","article-title":"2022update on clinical management of graves disease and thyroid eye disease","volume":"51","author":"Hoang","year":"2022","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"4","key":"10.1016\/j.intimp.2024.113955_b0115","doi-asserted-by":"crossref","first-page":"767","DOI":"10.47391\/JPMA.22-28","article-title":"Understanding the pathogenesis of Graves' orbitopathy: A new age paradigm, JPMA","volume":"72","author":"Kurian","year":"2022","journal-title":"J. Pak. Med. Assoc."},{"key":"10.1016\/j.intimp.2024.113955_b0120","doi-asserted-by":"crossref","unstructured":"P.N. Taylor, L. Zhang, R.W.J. Lee, I. Muller, New insights into the pathogenesis and nonsurgical management of Graves orbitopathy 16(2) (2020) 104\u2013116.","DOI":"10.1038\/s41574-019-0305-4"},{"issue":"5","key":"10.1016\/j.intimp.2024.113955_b0125","doi-asserted-by":"crossref","first-page":"D27","DOI":"10.1530\/EJE-19-0389","article-title":"Will biological agents supplant systemic glucocorticoids as the first-line treatment for thyroid-associated ophthalmopathy?","volume":"181","author":"Smith","year":"2019","journal-title":"Eur. J. Endocrinol."},{"issue":"12","key":"10.1016\/j.intimp.2024.113955_b0130","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nrg3813","article-title":"A census of human RNA-binding proteins","volume":"15","author":"Gerstberger","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.intimp.2024.113955_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102828","article-title":"RNA-binding protein hnRNP UL1 binds \u03baB sites to attenuate NF-\u03baB-mediated inflammation","volume":"129","author":"Ma","year":"2022","journal-title":"J. Autoimmun."},{"issue":"9","key":"10.1016\/j.intimp.2024.113955_b0140","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1002\/jcp.30311","article-title":"The oncogenic and tumor suppressive roles of RNA-binding proteins in human cancers","volume":"236","author":"Bitaraf","year":"2021","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.intimp.2024.113955_b0145","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1007\/s11010-021-04256-5","article-title":"RNA binding motif 47 (RBM47): emerging roles in vertebrate development, RNA editing and cancer","volume":"476","author":"Shivalingappa","year":"2021","journal-title":"Mol. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.intimp.2024.113955_b0150","doi-asserted-by":"crossref","first-page":"903","DOI":"10.15252\/embr.201438450","article-title":"C to U RNA editing mediated by APOBEC1 requires RNA-binding protein RBM47","volume":"15","author":"Fossat","year":"2014","journal-title":"EMBO Rep."},{"issue":"38","key":"10.1016\/j.intimp.2024.113955_b0155","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1038\/s41388-019-0892-5","article-title":"RBM47-regulated alternative splicing of TJP1 promotes actin stress fiber assembly during epithelial-to-mesenchymal transition","volume":"38","author":"Kim","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2024.113955_b0160","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1059325","article-title":"Prognostic analysis of m6A-related genes as potential biomarkers in idiopathic pulmonary fibrosis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.intimp.2024.113955_b0165","doi-asserted-by":"crossref","unstructured":"L.F. Lu, C. Zhang, X.Y. Zhou, Z.C. Li, D.D. Chen, Y. Zhou, F. Zhou, Y.A. Zhang, S. Li, Zebrafish RBM47 promotes lysosome-dependent degradation of MAVS to inhibit IFN induction, J. Immunol. (Baltimore, Md.: 1950) 205(7) (2020) 1819\u20131829.","DOI":"10.4049\/jimmunol.1901387"},{"key":"10.1016\/j.intimp.2024.113955_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.654473","article-title":"Cytokines as targets of novel therapies for graves' ophthalmopathy","volume":"12","author":"Fallahi","year":"2021","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.intimp.2024.113955_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103534","article-title":"Redox mechanisms in autoimmune thyroid eye disease","volume":"23","author":"Buonfiglio","year":"2024","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.113955_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2024.109812","article-title":"GSDMD mediated pyroptosis induced inflammation of Graves' orbitopathy via the NF-\u03baB\/AIM2\/Caspase-1 pathway","volume":"240","author":"Sha","year":"2024","journal-title":"Exp. Eye Res."},{"issue":"13","key":"10.1016\/j.intimp.2024.113955_b0185","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1167\/iovs.65.13.33","article-title":"Role of Lysyl oxidase-like protein 3 in the pathogenesis of graves' orbitopathy in orbital fibroblasts","volume":"65","author":"Park","year":"2024","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2024.113955_b0190","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1089\/thy.2023.0309","article-title":"Yes-associated protein mediates the transition from inflammation to fibrosis in graves' orbitopathy","volume":"33","author":"Ko","year":"2023","journal-title":"Thyroid: Off. J. American Thyroid Assoc."},{"issue":"4","key":"10.1016\/j.intimp.2024.113955_b0195","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41587-020-0481-8","article-title":"IGF-1R drugs travel from cancer cradle to Graves'","volume":"38","author":"Dolgin","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.intimp.2024.113955_b0200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.exer.2012.11.014","article-title":"Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy","volume":"107","author":"Zhao","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.intimp.2024.113955_b0205","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2147\/JIR.S339483","article-title":"MiR-143 targets IGF-1R to suppress autoimmunity in thyroid-associated ophthalmopathy","volume":"15","author":"Tang","year":"2022","journal-title":"J. Inflamm. Res."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924024779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924024779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:55:25Z","timestamp":1740617725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924024779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":41,"alternative-id":["S1567576924024779"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113955","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RBM47 as a potential therapeutic target for thyroid-associated ophthalmopathy","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113955"}}